MedTrace Logo

Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change

NCT01148030 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 333

Last updated 2014-03-03

No results posted yet for this study

Summary

Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.

Conditions

  • Surgical Site Infection

Interventions

DRUG

3M Skin and Nasal Antiseptic

Intra-nasal dosing

Sponsors & Collaborators

  • Sharp HealthCare

    collaborator OTHER

  • 3M

    lead INDUSTRY

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01148030 on ClinicalTrials.gov